Location: Webinar - Virtual
Start Date: Jul 09, 2024
Type of Event: Webinars

This webinar has since taken place. It is now available to watch on-demand.

About the Webinar

As episode 3 in our webinar series, “Quality Hits at Lightning Speed”, this webinar discusses Evotec’s most recent developments in biophysical screening approaches during early drug discovery stages.

Dr. Florian Krieger, VP Biophysics at Evotec, will share several case studies covering lead-like screening, fragment-based approaches, and covalent hit identification.

Meet Our Speaker

Headshot of Florian Krieger
Evotec logo big

Dr Florian Krieger

VP Biophysics

Evotec logo big

Latest update: June 2024

Biography 


Dr Krieger holds a Diploma in Biochemistry from the University of Halle (2000) with a focus on enzymology and obtained his Ph.D. in Biophysical Chemistry from the University of Basel (2004) in the field of protein folding. He then spent three years as a postdoctoral fellow at Louis Pasteur University Strasbourg studying the modulation of nicotinic acetylcholine receptor by small molecules.

In 2008 he joined Evotec as a Research Scientist and became member of the he biochemical Assay Development group. Since this time, he gained experiences in small molecule HTS approaches but also contributed to the setup of Evotec’s biophysics platform. Since 2022 Dr Krieger is heading the biophysics unit at Evotec Hamburg site as VP Biophysics.

Evotec logo big

Watch On-Demand

More About the Series

Learn more about the series and watch the previous parts on demand here.